Sees FY25 adjusted EBITDA between $53M-$63M. Sees FY25 free cash flow between $14M-$16M, assuming receipt of CARES Act refund in 2025. Sees new business wins ranging between $60M-$70M in FY25.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NNBR: